Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GRK2 inhibitors(G protein-coupled receptor kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H27FN6O5 |
InChIKeyKQJWWWZXJNOLQF-UHFFFAOYSA-N |
CAS Registry1870843-22-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Preclinical | US | 13 Apr 2016 |